Update: 16.07.2024
Last week: 27 week 2024 (01.07.2024 - 01.07.2024)
Last full month: June 2024
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 6 767 | -0.8% | 12.0% | -0.2 | 13 561 999 | -3.0% | 9.1% | -0.4 | 1.0% |
| MoM | 29 841 | -1.0% | 11.8% | 0.5 | 61 914 459 | -6.0% | 9.2% | -0.2 | -5.2% |
| YTD | 193 422 | 18.5% | 11.2% | 2.4 | 424 611 497 | 42.0% | 9.4% | 2 | -7.2% |
| MAT | 371 041 | 26.3% | 10.3% | 1.9 | 782 471 864 | 45.8% | 8.7% | 1.5 | 3.4% |
| BRAINMAX | |||||||||
| WoW | 1 246 | 27.0% | 100.0% | 0 | 4 748 230 | 28.3% | 100.0% | 0 | 27.0% |
| MoM | 4 696 | 10.2% | 100.0% | 0 | 17 434 089 | 10.9% | 100.0% | 0 | 9.5% |
| YTD | 28 136 | 40.3% | 100.0% | 0 | 102 537 623 | 52.3% | 100.0% | 0 | 40.3% |
| MAT | 54 732 | 81.2% | 100.0% | 0 | 196 221 303 | 96.4% | 100.0% | 0 | 81.2% |
| GOLDLINE PLUS | |||||||||
| WoW | 15 969 | -3.8% | 46.9% | 1 | 49 880 570 | -4.3% | 38.8% | 1.2 | -5.9% |
| MoM | 76 113 | -2.1% | 45.6% | 1 | 236 045 121 | -2.2% | 37.4% | 1.4 | -4.3% |
| YTD | 464 891 | -3.1% | 44.8% | 1.1 | 1 467 283 558 | 0.4% | 36.6% | -2.7 | -5.5% |
| MAT | 853 944 | 7.0% | 45.5% | 1.2 | 2 697 029 783 | 13.8% | 38.1% | -1.3 | 4.3% |
| MIGRENIUM | |||||||||
| WoW | 10 583 | -2.5% | 0.5% | 0 | 3 571 112 | -1.3% | 0.7% | 0 | 5.5% |
| MoM | 47 383 | -0.1% | 0.5% | 0 | 15 640 530 | 0.8% | 0.7% | 0 | 0.0% |
| YTD | 322 182 | -2.8% | 0.5% | -0.1 | 98 303 654 | 63.9% | 0.7% | 0.2 | 11.5% |
| MAT | 632 229 | 0.1% | 0.5% | -0.1 | 161 005 709 | 40.4% | 0.6% | 0.1 | 15.5% |
| MODELAX-N | |||||||||
| WoW | 23 400 | -22.6% | 20.1% | -6.3 | 10 904 063 | -20.0% | 13.5% | -4.2 | 1.5% |
| MoM | 129 928 | 13.6% | 25.5% | 4.3 | 57 903 671 | 13.1% | 17.0% | 2.9 | -5.5% |
| YTD | 819 088 | 41.5% | 23.6% | 4.9 | 348 294 152 | 91.6% | 15.1% | 4.6 | 12.1% |
| MAT | 1 408 066 | 71.2% | 21.2% | 6.3 | 549 352 310 | 108.0% | 12.8% | 4.4 | 20.1% |
| REDUXIN | |||||||||
| WoW | 10 932 | -5.1% | 32.1% | 0.3 | 56 883 200 | -8.3% | 44.2% | -0.5 | -5.9% |
| MoM | 53 172 | -8.5% | 31.9% | -1.5 | 280 788 156 | -10.0% | 44.5% | -2 | -4.3% |
| YTD | 341 759 | -8.7% | 32.9% | -1.2 | 1 842 767 086 | 16.5% | 45.9% | 3.4 | -5.5% |
| MAT | 605 293 | -2.0% | 32.3% | -2.1 | 3 133 797 080 | 21.6% | 44.3% | 1.4 | 4.3% |
| REDUXIN FORTE | |||||||||
| WoW | 3 173 | -0.3% | 9.3% | 0.5 | 13 479 093 | -3.7% | 10.5% | 0.4 | -5.9% |
| MoM | 14 938 | 0.8% | 9.0% | 0.5 | 64 502 909 | 0.3% | 10.2% | 0.6 | -4.3% |
| YTD | 90 694 | 1.9% | 8.7% | 0.6 | 394 260 626 | 17.2% | 9.8% | 0.8 | -5.5% |
| MAT | 167 691 | 17.4% | 8.9% | 1 | 711 344 842 | 30.8% | 10.1% | 1 | 4.3% |
| SALVISAR | |||||||||
| WoW | 7 904 | -4.6% | 1.2% | -0.1 | 3 522 787 | -4.2% | 1.1% | -0.1 | 0.9% |
| MoM | 39 304 | -24.6% | 1.3% | -0.3 | 16 958 303 | -22.9% | 1.2% | -0.3 | -6.8% |
| YTD | 279 508 | 2.1% | 1.4% | 0 | 112 323 283 | 26.8% | 1.2% | 0.1 | 0.3% |
| MAT | 504 148 | -12.3% | 1.3% | -0.3 | 187 498 526 | -3.2% | 1.1% | -0.2 | 5.5% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 193 422 | 18.5% | 11.2% | 2.4 | 424 611 497 | 42.0% | 9.4% | 2 | -7.2% |
| BRAINMAX | 28 136 | 40.3% | 100.0% | 0 | 102 537 623 | 52.3% | 100.0% | 0 | 40.3% |
| GOLDLINE PLUS | 464 891 | -3.1% | 44.8% | 1.1 | 1 467 283 558 | 0.4% | 36.6% | -2.7 | -5.5% |
| MIGRENIUM | 322 182 | -2.8% | 0.5% | -0.1 | 98 303 654 | 63.9% | 0.7% | 0.2 | 11.5% |
| MODELAX-N | 819 088 | 41.5% | 23.6% | 4.9 | 348 294 152 | 91.6% | 15.1% | 4.6 | 12.1% |
| REDUXIN CAPS | 341 759 | -8.7% | 32.9% | -1.2 | 1 842 767 086 | 16.5% | 45.9% | 3.4 | -5.5% |
| REDUXIN FORTE | 90 694 | 1.9% | 8.7% | 0.6 | 394 260 626 | 17.2% | 9.8% | 0.8 | -5.5% |
| SALVISAR | 279 508 | 2.1% | 1.4% | 0 | 112 323 283 | 26.8% | 1.2% | 0.1 | 0.3% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 371 041 | 26.3% | 10.3% | 1.9 | 782 471 864 | 45.8% | 8.7% | 1.5 | 3.4% |
| BRAINMAX | 54 732 | 81.2% | 100.0% | 0 | 196 221 303 | 96.4% | 100.0% | 0 | 81.2% |
| GOLDLINE PLUS | 853 944 | 7.0% | 45.5% | 1.2 | 2 697 029 783 | 13.8% | 38.1% | -1.3 | 4.3% |
| MIGRENIUM | 632 229 | 0.1% | 0.5% | -0.1 | 161 005 709 | 40.4% | 0.6% | 0.1 | 15.5% |
| MODELAX-N | 1 408 066 | 71.2% | 21.2% | 6.3 | 549 352 310 | 108.0% | 12.8% | 4.4 | 20.1% |
| REDUXIN CAPS | 605 293 | -2.0% | 32.3% | -2.1 | 3 133 797 080 | 21.6% | 44.3% | 1.4 | 4.3% |
| REDUXIN FORTE | 167 691 | 17.4% | 8.9% | 1 | 711 344 842 | 30.8% | 10.1% | 1 | 4.3% |
| SALVISAR | 504 148 | -12.3% | 1.3% | -0.3 | 187 498 526 | -3.2% | 1.1% | -0.2 | 5.5% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 6 767 | -0.8% | 12.0% | -0.2 | 13 561 999 | -3.0% | 9.1% | -0.4 | 1.0% |
| BRAINMAX | 1 246 | 27.0% | 100.0% | 0 | 4 748 230 | 28.3% | 100.0% | 0 | 27.0% |
| GOLDLINE PLUS | 15 969 | -3.8% | 46.9% | 1 | 49 880 570 | -4.3% | 38.8% | 1.2 | -5.9% |
| MIGRENIUM | 10 583 | -2.5% | 0.5% | 0 | 3 571 112 | -1.3% | 0.7% | 0 | 5.5% |
| MODELAX-N | 23 400 | -22.6% | 20.1% | -6.3 | 10 904 063 | -20.0% | 13.5% | -4.2 | 1.5% |
| REDUXIN CAPS | 10 932 | -5.1% | 32.1% | 0.3 | 56 883 200 | -8.3% | 44.2% | -0.5 | -5.9% |
| REDUXIN FORTE | 3 173 | -0.3% | 9.3% | 0.5 | 13 479 093 | -3.7% | 10.5% | 0.4 | -5.9% |
| SALVISAR | 7 904 | -4.6% | 1.2% | -0.1 | 3 522 787 | -4.2% | 1.1% | -0.1 | 0.9% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 29 841 | -1.0% | 11.8% | 0.5 | 61 914 459 | -6.0% | 9.2% | -0.2 | -5.2% |
| BRAINMAX | 4 696 | 10.2% | 100.0% | 0 | 17 434 089 | 10.9% | 100.0% | 0 | 9.5% |
| GOLDLINE PLUS | 76 113 | -2.1% | 45.6% | 1 | 236 045 121 | -2.2% | 37.4% | 1.4 | -4.3% |
| MIGRENIUM | 47 383 | -0.1% | 0.5% | 0 | 15 640 530 | 0.8% | 0.7% | 0 | 0.0% |
| MODELAX-N | 129 928 | 13.6% | 25.5% | 4.3 | 57 903 671 | 13.1% | 17.0% | 2.9 | -5.5% |
| REDUXIN CAPS | 53 172 | -8.5% | 31.9% | -1.5 | 280 788 156 | -10.0% | 44.5% | -2 | -4.3% |
| REDUXIN FORTE | 14 938 | 0.8% | 9.0% | 0.5 | 64 502 909 | 0.3% | 10.2% | 0.6 | -4.3% |
| SALVISAR | 39 304 | -24.6% | 1.3% | -0.3 | 16 958 303 | -22.9% | 1.2% | -0.3 | -6.8% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs